MedPath
NMPA Approval

Compound Amino Acid(16AA), Glucose(12.6%) and Electrolyte Injection

国药准字HJ20230064

June 7, 2023

Drug Information

复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液

注射剂

2000ml[复方氨基酸(16AA)电解质注射液1000ml;葡萄糖注射液(12.6%)1000ml]

化学药品

June 7, 2023

June 6, 2028

Company Information

Applicant Company

Hafnerstraβe 36, 8055 Graz, Austria

Manufacturing Company

Hafnerstraβe 36, 8055 Graz, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨基酸(16AA)/葡萄糖(12.6%)电解质注射液 - NMPA 批准文号 | MedPath